The Nigerian Society of Anaesthetists has confirmed it is monitoring allegations of medical negligence linked to the death of Nkanu Nnamdi, the 21-month-old son of acclaimed novelist Chimamanda Ngozi Adichie and her husband, Dr Ivara Esege.
Prof. Alhassan Mohammed, National President of the professional body, disclosed this during an interview with the News Agency of Nigeria on Saturday in Lagos, days after the family released a statement alleging that complications arising from inadequate monitoring during sedation led to the child’s death at a private hospital in Lagos.
According to an official family statement, Nkanu died on January 7 following what was described as a brief illness. The toddler had been taken to Euracare Hospital for an MRI scan and the insertion of a central line, medical procedures that required sedation. However, Adichie alleged in a subsequent statement that her son was administered propofol, a potent anaesthetic agent, but was not properly monitored during and after the procedure.
The statement detailed that the lack of adequate monitoring led to a cascade of life-threatening complications, including loss of responsiveness, seizures, and ultimately cardiac arrest. The family’s account raised serious questions about adherence to medical protocols and patient safety standards during anaesthetic procedures.
The statement, issued by Omawumi Ogbe of GLG Communications on behalf of the family, said, “The family is devastated by this profound loss, and we request that their privacy be respected during this incredibly difficult time.”
Sources close to the family have since alleged that the incident amounted to medical negligence at the Lagos private hospital where Nkanu was taken for medical procedures ahead of a scheduled evacuation to the United States for further treatment.
Speaking on the matter, Prof. Mohammed explained that the Nigerian Society of Anaesthetists was awaiting more detailed information before making further comments. He noted that any investigation into the allegations would likely involve multiple layers of inquiry, beginning with the hospital itself.
“The hospital involved is likely to conduct its own investigation for more facts by getting oral and documented evidence. You know the patient will have a record, whether manual or electronic, that can be printed out there. Then there may be an independent investigative panel to look further based on the allegations, depending on if the mother or relatives want to take it further,” Mohammed said.
He outlined that such investigations typically focus on several key areas: verification of the registration status of the individuals and facilities involved, compliance with approved scopes of practice, adherence to medical protocols, and identification of whether negligence contributed to the incident.
The NSA president’s remarks suggest that the case could trigger both internal hospital reviews and potentially broader professional scrutiny, depending on the family’s decision to pursue formal complaints or legal action.
Propofol is a widely used intravenous anaesthetic agent known for its rapid onset and short duration of action. It is commonly employed for sedation during diagnostic and minor surgical procedures, including MRI scans and central line insertions in paediatric and adult patients. However, its use requires strict adherence to safety protocols, including continuous monitoring of vital signs such as heart rate, oxygen saturation, blood pressure, and level of consciousness.
Medical guidelines issued by regulatory bodies and professional associations, including the Nigerian Society of Anaesthetists and international counterparts, emphasize that propofol should only be administered by trained personnel with expertise in airway management and resuscitation. Continuous monitoring is considered non-negotiable, particularly in paediatric cases where children are more vulnerable to rapid deterioration.
Failure to maintain adequate monitoring during sedation can lead to hypoxia (low oxygen levels), respiratory depression, cardiac complications, and in severe cases, death. The allegations raised by the Adichie family appear to centre on this critical aspect of patient safety.
Chimamanda Ngozi Adichie, one of Nigeria’s most celebrated literary figures and a globally recognised voice on African identity, feminism, and social justice, has kept a relatively low public profile regarding her personal life. The loss of her young son has drawn widespread sympathy and renewed attention to issues of medical accountability and patient safety in Nigeria’s healthcare system.
The circumstances surrounding Nkanu’s death have resonated deeply with many Nigerians who have experienced or witnessed lapses in medical care, particularly in private healthcare facilities where standards of practice and regulatory oversight vary widely.
While Euracare Hospital has not issued a public statement on the matter, the institution is expected to conduct an internal review of the incident, as is standard practice in cases involving adverse outcomes during medical procedures. Whether the hospital will make its findings public or whether the family will pursue further legal or regulatory action remains unclear.
The case has also reignited conversations about the state of medical regulation and accountability in Nigeria. The Medical and Dental Council of Nigeria, the country’s primary regulatory body for medical practitioners, has the mandate to investigate cases of alleged professional misconduct and medical negligence. However, enforcement of standards and disciplinary actions have often been criticized as slow and inadequate.
In recent years, there have been growing calls for stronger regulatory frameworks, better training and certification of medical personnel, and improved patient safety protocols across public and private healthcare facilities. The death of Nkanu Adichie has brought these issues back to the forefront, with many observers calling for transparency and accountability in the investigation process.
